Prot #MTI-103: A Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis (ATOMIK)

  • Silverberg, Jonathan I (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/17 → 9/15/20

Funding

  • Symbio, LLC (Prot #MTI-103 // Prot #MTI-103)
  • Menlo Therapeutics Inc. (Prot #MTI-103 // Prot #MTI-103)